Fairmount Healthcare Fund II GP LLC (CIK 1830382) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Buy VRDN (1.2M shares), Buy VRDN (454,545 shares), Buy VRDN (1,600 shares), Buy VRDN (12,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | Viridian Therapeutics, Inc.\DE (VRDN) | Director | Buy | 1.2M | $20.0M |
| 2025-10-27 | Viridian Therapeutics, Inc.DE (VRDN) | Director | Buy | 454,545 | $10.0M |
| 2025-06-11 | Viridian Therapeutics, Inc.DE (VRDN) | Director | Buy | 1,600 | $12,480 |
| 2025-06-11 | Viridian Therapeutics, Inc.DE (VRDN) | Director | Buy | 12,500 | $153,875 |
Source: SEC Form 4 filings · as of 2026-05-13